The Sonnets of Luis de Góngora R. P. Calcraft

Autor: Gornall, J. F. G.

Publikováno v: The Modern Language Review, 1982 Jul 01. 77(3), 748-750.

Externí odkaz: https://www.jstor.org/stable/3728117

Pediatric perianal Crohn's disease behavior in the era of biologic therapy.

Autor: De La Puente, S.¹ santiagodelapuenteperez@gmail.com, Góngora, R. Espinosa¹, Romero, H. Souto¹, Espiñeira, C. Rico¹, Huertas, A. L. Luis¹, Visier, C. Garcés¹, Rodríguez, P. Ramos¹, Hernández, D. Muñoz¹, Vega, M. L. Espinoza¹, Ruiz, J. A. Acedo¹, Maruszewski, P.¹, Riñón, C.¹, Robert, P. Morató¹, Palomino, L.², Velasco, M.², Vega, A. Martín³, Calderón, J. L. Alonso¹

Publikováno v: Cirugía Pediátrica (English Edition). 2023, Vol. 36 Issue 1, p22-27. 6p.

Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation.

Autor: Juanes-Velasco P; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Arias-Hidalgo C; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., García-Vaquero ML; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Sotolongo-Ravelo J; Oncohematology Group, Cancer Research Center (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain., Paíno T; Oncohematology Group, Cancer Research Center (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain.; Department of Physiology and Pharmacology, University of Salamanca, 37007 Salamanca, Spain., Lécrevisse Q; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Landeira-Viñuela A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Góngora R; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Hernández ÁP; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Pharmaceutical Sciences, Organic Chemistry, Faculty of Pharmacy, University of Salamanca, CIETUS, IBSAL, 37007 Salamanca, Spain., Fuentes M; Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Proteomics Unit-IBSAL, Instituto de Investigación Biomédica de Salamanca, Universidad de Salamanca, (IBSAL/USAL), 37007 Salamanca, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 03; Vol. 25 (17). Date of Electronic Publication: 2024 Sep 03.

Functional proteomics based on protein microarray technology for biomedical research.

Autor: Juanes-Velasco P; Department of Medicine and General Cytometry Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain., Arias-Hidalgo C; Department of Medicine and General Cytometry Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain., Landeira-Viñuela A; Department of Medicine and General Cytometry Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain., Nuño-Soriano A; Department of Medicine and General Cytometry Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain., Fuentes-Vacas M; Department of Medicine and General Cytometry Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain., Góngora R; Department of Medicine and General Cytometry Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain., Hernández ÁP; Department of Medicine and General Cytometry Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain; Department of Pharmaceutical Sciences: Organic Chemistry, Faculty of Pharmacy, University of Salamanca, CIETUS, IBSAL, Salamanca, Spain., Fuentes M; Department of Medicine and General Cytometry Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain; Proteomics Unit, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain. Electronic address: mfuentes@usal.es.

Publikováno v: Advances in protein chemistry and structural biology [Adv Protein Chem Struct Biol] 2024; Vol. 138, pp. 49-65. Date of Electronic Publication: 2023 May 15.

Comportamiento de la afectación perianal en pacientes pediátricos con enfermedad de Crohn en la era de la terapia biológica. (Spanish)

Autor: De La Puente, S., Espinosa Góngora, R., Souto Romero, H., Rico Espiñeira, C., Luis Huertas, A. L., Garcés Visier, C., Ramos Rodríguez, P., Muñoz Hernández, D., Espinoza Vega, M. L., Acedo Ruiz, J. A., Maruszewski, P., Riñón, C., Morató Robert, P., Palomino, L., Velasco, M., Martín Vega, A., Alonso Calderón, J. L.

Publikováno v: Cirugía Pediátrica; ene2023, Vol. 36 Issue 1, p22-27, 6p